← Back to Search

Other

Personal Hand Hygiene System for Surgical Site Infection (ESKAPE Trial)

N/A
Recruiting
Led By Brandon M Togioka, MD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients ≥ 18 years of age having surgery in an adult operating suite at the research center involving the following specialties: orthopedics/spine, orthopedics/total joint, gynecology/oncology, colorectal, open vascular, and open urological, general abdominal, acute care, cardiothoracic, and plastic/breast.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days following surgery
Awards & highlights

ESKAPE Trial Summary

This trial will test if a new hand hygiene system can decrease exposure to pathologic bacteria in the operating room.

Who is the study for?
This trial is for adult anesthesia providers and patients undergoing certain surgeries at the research center. Providers must be involved in adult surgeries, while patients need to be adults having specific types of surgery like orthopedics or cardiothoracic. Excluded are those with open hand sores, prisoners, pregnant women, anyone unable to consent, known infections at surgery time, refusal to consent, skin infections or allergies to hand hygiene solutions.Check my eligibility
What is being tested?
The study tests a personal hand hygiene system called SafeHavenTM used by anesthesia providers during operations. It aims to reduce exposure to harmful bacteria in the operating room when combined with an infectious pathogen tracking system named OR PathTrac.See study design
What are the potential side effects?
While not explicitly listed in the provided information, potential side effects may include skin irritation or allergic reactions due to components of the hand hygiene solution such as ethyl alcohol.

ESKAPE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older and having surgery in one of the listed specialties at the research center.

ESKAPE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days following surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days following surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of ESKAPE (Enterococcus, S. Aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) reservoirs identified using microbial culture collection kits
Secondary outcome measures
Acinetobacter
Quantitate the reduction in ESKAPE (Enterococcus, S. Aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) transmission events

ESKAPE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Use of SafeHaven hand hygiene system in the operating room
Group II: Control ArmActive Control1 Intervention
Standard of care hand hygiene

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
974 Previous Clinical Trials
7,385,872 Total Patients Enrolled
Georgia-Pacific Consumer Products LPUNKNOWN
University of IowaOTHER
447 Previous Clinical Trials
879,682 Total Patients Enrolled

Media Library

SafeHaven Automated Hand Hygiene Device (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04900298 — N/A
Surgical Site Infection Research Study Groups: Intervention Arm, Control Arm
Surgical Site Infection Clinical Trial 2023: SafeHaven Automated Hand Hygiene Device Highlights & Side Effects. Trial Name: NCT04900298 — N/A
SafeHaven Automated Hand Hygiene Device (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04900298 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been approved to take part in this clinical experiment?

"Indeed, clinicaltrials.gov shows that this medical investigation is recruiting participants as of April 20th 2022. It was initially opened to the public on January 1st and is looking for 40 people at a single location."

Answered by AI

Are any new participants being welcomed into this clinical trial at the moment?

"Clinicaltrials.gov confirms that this clinical study, initially posted on January 1st 2022 and last revised on April 20th 2022, is presently recruiting participants."

Answered by AI

Who meets the qualifications to take part in this investigation?

"The research center is inviting 40 individuals with cross-infection to the trial, specifically those aged 18 through 99. Prerequisites include: adult patients undergoing surgery in orthopedics/spine, orthopedics/total joint, gynecology/oncology, colorectal, open vascular and open urological surgeries; general abdominal operations; acute care cases; cardiothoracic interventions; or plastic/breast procedures."

Answered by AI

Is the patient pool for this trial limited to those under seventy years of age?

"In accordance with the eligibility guidelines for this research, individuals between 18 and 99 years old may participate."

Answered by AI
~9 spots leftby Dec 2024